Abstract
Aim: this work investigated the effects of different early resuscitation fluid replenishment rates (FRRs) on inflammation (serum interleukin-6 (IL-6) and C-reactive protein (CRP), PCT ) and complications in patients with severe acute pancreatitis (SAP).
Methods: Sixty-six patients with SAP were studied. According to the ratio of total fluid replenishment 24 h after admission to that 72 h (FRR), the patients were rolled into a low FRR group (Low group), a moderate FRR group (Moderate group), and a high FRR group (High group), with 22 cases in each. Serum related indexes, APACHE Ⅱ score, HCT, systemic inflammatory response syndrome (SIRS) duration, length of hospital stay (LOS), and complication rate (CR) were determined and compared. Results: The results suggested that ALT, AST, SCr, BUN, TBil, APACHE Ⅱ, scores and HCT in the Moderate group were the lowest (P<0.05), while those in the High group were the highest (P<0.05). After the patients were treated for 72 h, the IL-6, CRP, and PCT in the Low group and the High group were higher than those in the Moderate group, exhibiting differences with P<0.05 and P<0.01, respectively. The SIRS duration and LOS in the Low and High groups were longer and presented differences with P<0.05 and P<0.01 to the Moderate group, respectively. The rates of MODS, mechanical ventilation, pancreatic necrosis infection, and death in the Moderate group were the lowest (P<0.05).
conclusion the moderate FRR could effectively alleviate the inflammatory response of patients with SAP, shorten the treatment time, and reduce the CR
Keywords
References
The published articles will be distributed under the Creative Commons Attribution 4.0 International License (CC BY). It is allowed to copy and redistribute the material in any medium or format, and remix, transform, and build upon it for any purpose, even commercially, as long as appropriate credit is given to the original author(s), a link to the license is provided and it is indicated if changes were made. Users are required to provide full bibliographic description of the original publication (authors, article title, journal title, volume, issue, pages), as well as its DOI code. In electronic publishing, users are also required to link the content with both the original article published in Journal of Medical Biochemistry and the licence used.
Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.